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Introduction: The cerebrovascular accident ranks among the main causes of mortality and
morbidity worldwide. In the Czech Republic, the cerebrovascular disease was the direct
cause of death in 10% of the cases in the year 2012 (Healthcare Annual CZ 2012).
Aim: The aim of our study was to evaluate the transoesophageal echocardiogram ﬁndings
(TOE) in patients with suspicion for cardioembolic stroke or TIA who were indicated to this
examination in our echocardiography laboratory.
Methodology: During the period from July 2009 to March 2013 (45 months), 108 TOE had been
realized in our echocardiographic laboratory that was indicated for ischaemic stroke or TIA.
We monitored the occurrence of pathological ﬁndings that have the cardioembolic potential
according to the literature.
Results: The examination was performed for a suspect of an infective endocarditis 10 times,
this was proven in 3 cases. 5 patients were holders of a mechanical valvular prosthesis, and
its dysfunction was discovered in neither case. The most frequent diagnosis was foramen
ovale patens in the other patients (30 patients, i.e. 37%); in 3 cases it occurred simultaneously
with an atrial septal aneurysm. We found a haemodynamic little signiﬁcant atrial septal
defect in 3 patients and a presence of an endocardial thrombus in 2 patients. A left atrial
dilation and a systolic dysfunction of a left atrium auricle can relate with an occurrence
of an atrial ﬁbrillation. A left atrium volume was determined in 86 cases; only 35 patients
(i.e. 40.7%) have the normal left atrium volume. A pathology, which can be connected with a
cerebral ischaemia that took place, was found in 56% of the patients.
Conclusion: Transoesophageal echocardiography is an independent method in examination
of potential sources of cardioembolism. In our sample, a pathology in more than half of the
patients was diagnosed that could refer to a suffered ischaemic stroke and the diagnosis led
to a change in a treatment strategy in 17 cases of the total number of 95 patients (i.e. at 18%).
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The cerebrovascular accident ranks among the main causes
of the mortality and morbidity worldwide. In the Czech
Republic, the cerebrovascular disease was the direct cause
of death in 10% cases in the year 2012 (Healthcare Annual
CZ 2012). It is predictable that the increasing life
expectancy and the growing incidence of stroke risk factors
in population will bring even higher incidence and preva-
lence [1].
The therapy of patients with the ischaemic form of stroke
or the transient ischaemic attack (TIA) – which is considered
an equivalent clinical unit – includes not only the acute
treatment but, in addition to that, the earliest possible
assessment of the aetiology for the purpose of secondary
prevention.
Cardioembolism is one of the possible causes of the stroke.
It is responsible for about 15–30% of ischaemic attacks [2–4].
The prognosis of patients with cardioembolic type of stroke is
signiﬁcantly adverse – 50% of the patients die within 3 years
and unidentiﬁed origin of the embolization increases the
incidence of the next attack two to three times [2,5].
Recognition of aetiology is the basic principle here, as an
accurate diagnosis often initiates a change of the therapy
strategy.
Cardioembolic aetiology is suspected if the neurological
deﬁcit develops rapidly. The neurological deﬁcit is the largest
at the beginning and it is mostly severe. The ischaemia most
often affects the cortex or it causes subcortical lenticulostriate
infarctions. The infarctions may be multilocular and of
different time of origin. More systemic thromboembolic
symptoms can be present (affecting e.g. kidneys or spleen)
[2,5].
The most common origin of cardioembolism is the atrial
ﬁbrillation – be it paroxysmal, persistent, or the chronic one
(it is supposed to be responsible for 50% stroke of cardioem-
bolic origin) [2]. Other diseases like acute myocardial infarc-
tion, ischaemic cardiomyopathy (mostly with aneurysm
formed in the left ventricle), dilated cardiomyopathy, patho-
logical intracardial mass presence (intracardial thrombus or
tumour), vegetation in infective endocarditis, rheumatic heart
disease (especially mitral stenosis) and the presence of a
mechanical valve prosthesis signiﬁcantly increase the cardi-
oembolic disease incidence. Other possible factors with lower
risk include the patent foramen ovale, presence of an atrial
septum aneurysm, aortic valve calciﬁcation, mitral annular
calciﬁcation, mitral valve prolapse or giant Lambl's excres-
cences [2,4,6,7].
In many cases, the presence of a heart disease that is
behind the cardioembolic stroke is evident as soon as the
patient' history has been taken and the initial examinations
routinely done at every patient have been done (ECG – 12-lead
graphic record and continual heart rhythm monitoring after
the patient's admission) [1]. A transthoracic echocardiographic
examination is performed if need be. If these examinations do
not reveal an embolic origin, the transoesophageal probe
examination is indicated. Generally it is indicated in younger
patients with ischaemic stroke of unknown origin, patients
with valve prosthesis, and patients with suspected infectiveendocarditis [3,5] and in the case of a difﬁcult interpretable
transthoracic diagnosis.
Aim
In the present literature only limited information is available
about ﬁndings in transoesophageal echocardiographic exam-
inations in patients with ischaemic stroke or TIA. Available
papers dealing with this issue come from the nineties, their
conclusions may therefore be difﬁcult to interpret in retrospect
because of an advance in a technical quality of echocardio-
graphic apparatus and transoesophageal probes (nowadays
multiplanar are used as a standard) and development of view
of a cardioembolic potential of the individual heart diseases
[6,8]. The aim of our study was to evaluate the actual
transoesophageal echocardiographic ﬁndings (TOE) in
patients with suspicion for cardioembolic stroke or TIA who
were indicated to this examination in our echocardiography
laboratory.
Methodology
During the period from July 2009 to March 2013 (45 months),
1207 TOE had been realized in our echocardiography laborato-
ry. 95 patients from this group were put into our group. These
are patients who suffered an ischaemic stroke or TIA.
Everybody was examined by a neurologist on admission. He
indicated a graphic examination of the brain and the afferent
cerebral arteries, according to a clinical situation and he
expressed a suspicion of cardioembolic aetiology of the
ischaemic stroke/TIA. It was thought of the cardioembolic
aetiology of an ictus in the case of a typical clinical picture and
an anamnesis, a diagnosis compatible with a cerebral
ischaemia on the graphic examinations and simultaneously
an absence of a signiﬁcant stenosis of an ipsilateral carotid
artery (i.e. stenosis ≥50%) or a vertebral artery. In the case of
the patients with TIA an exclusion of the signiﬁcant stenosis of
the ipsilateral carotid artery or the vertebral artery and the
typical clinical picture was enough. The age of the patients was
not a deciding factor in indicating TOE. There were 75 patients
with the ischaemic stroke in total and 20 patients with TIA in a
carotid and vertebrobasilar basin. The patients with lacunar
infarcts were not included in the group.
Chart 1 presents a representation of the individual graphic
examinations used for diagnostics of the cerebral ischaemia
and an imaging of the afferent cerebral arteries.
In order to get the basic characteristics of the patients
(present risk factors of stroke, comorbidity, antithrombotic
therapy at the beginning of the stroke), we used the patients'
medical records.
Echocardiographic examination with transoesophageal
probe itself always followed after transthoracic examination.
An examining echocardiographist decided on the indication of
TOE deﬁnitively. A patient was equipped with peripheral vein
catheter for application of premedication. Subsequently it was
used for application of the echo contrast not passing through
pulmonary microcirculation; in our case, the agitated physio-
logical solution was used.
rebmuNdohteM  of  paent s %
Noncontrast CT   6.1978nacs
Contrast  CT  scan  74 77.9
Magnec  6.2313ecnanoser
rebmuNdohteM  of  paent s %
Duplex Ultrasonograph y 20 21.1
CT  9.8757yhpargoigna
MR  2.33yhpargoigna
Digital subtracon  angiography 4 4.2
Brain imaging
Large vessels imaging
Chart 1 – Brain and large vessels imaging.
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have the cardioembolic potential according to the literature.
A thrombus is deﬁned as echo dense mass distinguishable
from endocardium, formed in left atrium or left ventricle. It is
observable in at least two views and it is distinguishable from
the pectinate muscles and trabeculae. It typically occurs in the
left atrium auricle, or in its apex. Most often it adheres to the
side in the left ventricle which is hypokinetic or akinetic, and is
obvious both during systole and diastole [5].
A tumour is another intracardial solid formation with
cardioembolic potential. The most common primary tumour
we can ﬁnd in the heart is the myxoma. It is a movable
polypoid formation attached to the endocardial tissue by a
stem, most frequently found in the left atrium in the area of
fossa ovalis; less common is the myxoma in the right atrium or
the left ventricle. The papillary ﬁbroelastoma is the most
common tumour of the valves and it is morphologically hard
to distinguish from vegetation [9].
Vegetation is the mass adhering to the valve and usually it
is distinguishable by its echogenicity and its active movement
independent on the valve. In fewer cases the vegetation can
adhere to papillary muscles, to the suspension apparatus of
the cuspid valves or the endocardium of cardiac cavities [5].
The presence of a patent foramen ovale (PFO) was identiﬁed
by the means of agitated physiological solution (i.e. echo
contrast not passing through pulmonary microcirculation)
applied into the peripheral vein. The presence of microbubbles
in the left atrium during 3 cycles following the opaciﬁcation of
the right atrium (either spontaneous, or using the Valsalva
manoeuvre) was considered the diagnosis of a PFO presence
[10]. The size of a shunt could not be determined from the
documentation unambiguously and so in all cases, we gave in
the evaluation of this parameter.
An atrial septal aneurysm was deﬁned as a permanent
prolapse at the area of fossa ovalis with the base diameter
10 mm at least, either a prolapse protruding at least 10 mm in
one direction, or an intermittent prolapse into the left/right
atrium with the excursion of at least 10 mm [5,11]. Its
occurrence usually coincides with PFO.
An aortic valve calciﬁcation was deﬁned as a hyperecho-
genity of the tip connected with its lower mobility, and the
mitral valve calciﬁcation as a hyperechogenity of a lumpy
shape of 3 mm in the diameter at least [3].A mitral valve prolapse was deﬁned as a systolic displace-
ment of a leaﬂet or leaﬂets at least 1 mm relative to the line
connecting annular hinge points in parasternal long axis
projection.
Stages IV and V (complex sclerotic plates at least 4 mm
wide, occasionally with a mobile component – thrombus),
were considered a signiﬁcant atherosclerotic involvement of
the thoracic aorta [5].
The left atrium volume was examined in relation to the risk
of paroxysmal atrial ﬁbrillation as a cause of ischaemic stroke.
The size was divided into categories according to the volume,
covering normal volume (22  6 ml/m2), mild dilatation (29–
33 ml/m2), moderate dilatation (34–39 ml/m2) and severe left
atrium dilatation (≥40 ml/m2) [12]. In some of the patients, the
ejection speed of the left atrium auricle was determined.
Results
Our set of patients consisted of 95 people. Their basic
demographic data, atherosclerotic risk factors and other
associated diseases are presented in Chart 2. In 88 cases it
was possible to identify what antithrombotic therapy the
patient was given before the onset of ischaemic stroke/TIA (see
Chart 3).
In average, the transoesophageal echocardiography was
performed 19 days following the ischaemic stroke/TIA (SD 34,
the absolute time span between the stroke and the examina-
tion was 0–169 days). For the ﬁndings see Chart 4.
Knowledge of the clinical situation, in which the examina-
tion was indicated, is necessary for the precise interpretation
of the diagnoses of the transoesophageal echocardiography.
As mentioned above, there are several indications for the
transoesophageal probe examination – the suspect of the
infective endocarditis, the presence of the mechanical valve
prosthesis, the ictus in the patients, which origination could
not be explained by an atherosclerotic affection of the afferent
cerebral arteries, and the patients with the difﬁcult interpret-
able transthoracic diagnosis.
The suspect of the infective endocarditis (i.e. a febrile
condition and elevation of inﬂammatory parameters at the
time of the ictus origination) was in our group of indications
for execution of the transoesophageal echocardiography in
Therapy Number  of  paent s %
Eﬀecve  warfarinisao n 6 6.4
Ineﬀecve  warfarinisao n 0 0
Acetylsalicylic aci d 8 8.4
1.11lergodipolC
Dual anplatelet  therapy 3 3.1
1.11HWML
No  6.2796tnemtaert
Unknown treatmen t 7 7.3
Chart 3 – Antithrombotic therapy before onset of ischaemic stroke/TIA.
Number of  paent s %
Gender - 8.6545elam
                - female 2.3414
Arterial  9474noisnetrepyh
Diabetes  4.88sutillem
Nicone  9.8373noitcidda
0675aimedipilsyD
Chronic lower limb   2.445aimehcsi
Ischemic  heart   2.44esaesid
2.33DPOC
1202ytisebO
Atrial  5.99noitallirbif
egarevAegA  52  years  (19–83 years)
Chart 2 – Basic demographical data, cardiovascular diseases and risk factors.
c o r e t v a s a 5 6 ( 2 0 1 4 ) e 4 5 6 – e 4 6 2 e45910 patients. This diagnosis was conﬁrmed in 3 of them. In other
cases, 2 patients had a respiratory infection, in 1 patient the
source of the infection was a carious dentition, and in other
one it was a wound on a lower arm after a dog bite. The source
of the infection could not be identiﬁed 2 times. In the last
patient was the non-infectious inﬂammation, it was an
autoimmune vasculitis. In this group of patients the diag-
nostics focused from the beginning on the presence of
vegetation, or paravalvular spread of the inﬂammation. From
the point of view of the suffered ictus the patients were treated
after exclusion of the infective endocarditis by the standardNum
Foramen ovale   snetap
Atrial septal  msyruena
Atrial septal  tcefed
Thoracic  aorc  atherosclerosi s 
Aorc valve   noitacificlac
Mitral  valve   noitacificlac
Mitral  valve   espalorp
Infecve  sitidracodne
Intracardiac  thrombus 
Le ventricle systolic  dysfuncon 
Negave  gnidnif
Chart 4 – Oesophageal echocardiographyanti-aggregation treatment or the anticoagulant treatment, if
they had the atrial ﬁbrillation.
Another group of the patients indicated for the transoeso-
phageal probe examination were 5 patients with valvular
prosthesis. Its dysfunction, the presence of the thrombus or
the vegetation was not established in a single one.
After exclusion of the patients with the suspect of the
infective endocarditis and with the valvular prosthesis, the
group of the patients with the ictus remains, which could not
be explained by the atherosclerotic affection of the cerebral
arteries. These are 81 patients. Their average age was 48 years,ber of  paent s %
6.1303
2.33
2.33
8 8.4
4.77
2.33
2.33
2.33
2 2.1
4 4.2
3414
 findings in whole group of patients.
Number of  paent s %
Foramen ovale   7303snetap
Atrial septal  7.33msyruena
Atrial septal  7.33tcefed
Thoracic  aorc  atherosclerosi s 6 7.4
Aorc valve  calciﬁcao n 5 6.2
Mitral  valve  calciﬁcao n 1 1.2
Mitral  valve   2.11espalorp
Intracardiac  thrombus 2 2.1
Le ventricle systolic  dysfuncon 2 2.5
Negave  7.5473gnidnif
Chart 5 – Oesophageal echocardiography findings in patients with ischaemic stroke/TIA of unknown origin.
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echocardiography diagnoses of this subgroup of the patients
are stated in the Chart 5 in the summary.
The most frequent diagnosis here was the foramen ovale
patens, it was discovered in 37% of the patients. In 3 cases it
was connected with the presence of the atrial septal aneu-
rysm. Another possible basis for a paradoxical embolization is
the atrial septal defect, which was discovered in 3 patients in
this subgroup. All of the atrial septal defects were insigniﬁcant
in terms of haemodynamics.
A thrombus was found only in 2 patients; in one of the cases
it adhered to the mitral valve (the thrombus was conﬁrmed by
a histological examination after the surgical removal), the
other was located in the left atrium auricle.
In the subgroup of the ischaemic stroke/TIA of the
unknown origin was quite negative diagnosis present in 46%
of the patients. In the whole group (i.e. including the patiens
examined for the suspect of the infective endocarditis and the
patients with the valvular prosthesis) the negative diagnosis
was present in 43% of the patients.
The atrial ﬁbrillation was present altogether in 9 patients
from the whole group. It is by itself the indication for the
anticoagulant treatment. Reasons for why was the examining
programme in these patients extended by TEE as were following
– the suspect of the infective endocarditis (in 2 patients), the
presence of the valvular prosthesis (in 2 patients), effective
warfarinization at the time of origin of the cerebral ischaemia
(3 patients), and the unclear transthoracic diagnosis with the
suspect of a waving structure on a mitral valve (1 patient). The
paroxysmal atrial ﬁbrillation was discovered in the last patient
only after the transoesophageal echocardiography.
The left atrium volume was determined in 86 cases (see
Chart 6 for the results). Only 35 patients (40.7%) had a normaleziS
Normal size  16–28 ml/m 2 
Mild  dilatao n 29–33  ml/m 2 
Moderate   dilatao n 34–39 ml/m 2 
Sever  dilataon ≥40  ml/m 2 
Chart 6 – Left aleft atrium volume. The ejection speed of the left atrium
auricle was determined in 27 cases. Low speed (less than
0.5 m/s) was registered in 4 patients. It was always connected
with severe left atrium dilatation and in one case with atrial
ﬁbrillation.
Discussion
The echocardiographic examination with oesophageal probe
should either conﬁrm or eliminate the presence of diseases
that need a change in the therapy strategy in patients with
ischaemic stroke or TIA. This examination is generally
indicated in patients with suspected cardioembolic aetiology
of ischaemic stroke/TIA that was not proven by non-invasive
tests including transthoracic echocardiography, in patients
with suspected infective endocarditis, and in patients with
mechanical valve prosthesis.
An ischaemic stroke connected with permanent atrial
ﬁbrillation is a clear indication for permanent anticoagulation
therapy. Sometimes it is difﬁcult to diagnose paroxysmal atrial
ﬁbrillation in a patient with stroke of unknown origin if the
arrhythmia has not been detected during the admission of the
patient to the stroke unit or during the subsequent monitoring
[5,13]. In such a case the oesophageal echocardiography can
help with evaluation of the left atrium volume, the left atrium
auricle function and, although rather rarely, it may display the
thrombus itself. The heavily dilated left atrium and the low
ejection speed of the auricle is the sign of the dysfunction of
the left atrium. It is by itself suspected of the possible
occurrence of the atrial ﬁbrillation. A rhythm monitoring
extension with Holter ECG or reveal loop monitoring after the
discharge seems to be a reasonable decision [14].%rebmuN
35 40.7
22 25.6
10 11.6
19 22.1
trium size.
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to an ischaemic stroke is an indication for permanent
anticoagulation treatment as well. This therapy is inevitable
especially in the case of big movable thrombi protruding to the
left ventricle cavity or in the case of thrombi detected in
relation to an acute heart attack. Sessile thrombi attached to
the wall constitute lower cardioembolic risk. A transthoracic
echocardiographic examination for thrombus detection in the
left ventricle is usually sufﬁcient [5], which is possibly the
reason why there was no occurrence of an intraventricular
thrombus in our sample. However, it is necessary to under-
stand thromboembolism as a dynamic process. It is possible
for a thrombus to form in the heart and to embolize
subsequently, leaving no obvious residues detectable by
echocardiography until a new thrombus is formed. In a
cardioembolic incident, any pathology i.e. the dilatation and
the heavy systolic dysfunction of the left ventricle or the
presence of the post-infarct aneurysm that has a disposition
for the formation of intracardial thrombi should be a sufﬁcient
reason for an anticoagulation therapy [2].
A change in treatment strategies in patients with a stroke is
unavoidable if vegetation has been found and, therefore,
infectious endocarditis diagnosed. The diagnosis of such a
case is the domain of oesophageal echocardiography.
The most common heart tumours are metastatic or
malignant tumours growing through the heart tissue. In such
cases, the basic disease has been usually diagnosed earlier and
the disease is in an advanced stage already. Echocardiography
can bring signiﬁcant beneﬁts in the diagnosis of primary
benign tumours [9]. These, however, are very rare and no case
of brain ischaemia had an origin in a heart tumour in our
sample.
The oesophageal echocardiography is an excellent modali-
ty for presenting minor cardiac shunts that create the
pathophysiological basis for paradoxical embolism. Patent
foramen ovale is the most common of them and its incidence
in population is between 25% and 30% [4,16]. In our sample,
37% of patients with ischaemic stroke/TIA of unknown origin
have been identiﬁed to have PFO. The systemic embolism risk
increases with the occurrence of an atrial septal aneurysm and
with the size of the shunt. A shunt is considered large if over 20
microbubbles get to the left atrium during Valsalva manoeuvre
[5,17]. Patients with suspected paradoxical embolism through
PFO causing ischaemic stroke may be treated, apart from
antithrombotic therapy, with a shunt closure by the means of
an occluder. The recent RESPECT and PC Trial studies' results
are available [10,7], which allow for a conclusion that the
transcatheter closure in correctly indicated patients is no
inferior option compared to antithrombotic therapy. In our
sample, the closure was indicated and implemented in 11
cases of 30 PFO detected. These patients were then treated by
the dual antiplatelet therapy (acetylsalicylic acid + clopidogrel)
for 6 months, then by the monotherapy with the acetylsalicylic
acid permanently. It was proceeded conservatively in the other
19 patients on account of their preference, eventually on the
basis of the indication for the anticoagulant treatment on
account of the present coagulation disorder.
The signiﬁcance of the mitral valve prolapse is question-
able. Historically, it was considered a classical cardioembolic
source. At present, this mitral valve inﬂiction is regarded asgenerally benign and its possible connection with cardioem-
bolism as unproven [2,18]. Its occurrence was low also in our
sample.
The role of calciﬁcations in the mitral annulus in the
cardioembolic formation is similarly controversial. Patients
with this kind of inﬂiction have higher incidence of cardio-
vascular disease and death but it is attributed mostly to the
atherosclerotic inﬂiction of cardiovascular apparatus (either
obvious or subclinical) rather than cardioembolism. Further
treatment should be derived from the associated diseases
(such as IHD, atrial ﬁbrillation, etc.) [2,19].
An isolated degenerative aortic valve inﬂiction is not
considered a disease with clinically signiﬁcant embolic
potential either.
An aortic atherosclerotic involvement can be diagnosed by
TOE. It can be the cause of embolism to CNS. This is not
a cardioembolic stroke but the embolism coming from the
great blood vessels (the subtype I according to TOAST criteria).
The treatment in this case should be aimed at massive
reduction of LDL cholesterol. Both antiaggregation therapies
using acetylsalicylic acid and anticoagulation warfarin
therapy can be considered. The new ARCH study will,
hopefully, help us decide which antithrombotic therapy is
preferable in this case.
Conclusion
Determination of the correct aetiology of the cerebrovascular
accident or the transitory ischaemic attack is essential for the
decision for the long-term treatment to reduce the risk of the
ictus recurrence. If the patient suffers the cerebral ischaemia
and the signiﬁcant carotid stenosis was not discovered, he will
be treated by the antiplatelet therapy standardly. This need
not be sufﬁcient in the case of the cardioembolic aetiology of
the ictus.
Transoesophageal echocardiography is an independent
method in examination of potential sources of cardioembo-
lism. In our sample, a pathology in more than half of the
patients was diagnosed that could refer to a suffered
ischaemic stroke and in 17 cases (i.e. at 18%) it led to the
change of the treatment strategy – the infective endocarditis
was treated in 3 cases, the patient was indicated for the
anticoagulant treatment for the diagnosis of the thrombus in
the left atrium auricle in 1 case, the structure from the mitral
valve was removed cardiosurgically at 1 time (it was diagnosed
also as the thrombus on the basis of the histological analysis
consequently), the patient underwent the catetherization
closure of the atrial septal defect in 1 case and FOA was
occluded 11 times.
However, not every heart inﬂiction has the same cardioem-
bolic potential and many heart diseases coexist with athero-
sclerosis in other locations including CNS.
An echocardiographer who examines the patient with
ischaemic stroke should be aware of these issues. He/she
should perform the examination concerning all clinical units
of embolic potential relevant for the decision on the subse-
quent treatment. The ﬁnding is to be always interpreted within
the context of the results of other examinations and patient's
comorbidity.
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